- Previous Close
0.4850 - Open
0.5000 - Bid 0.4850 x --
- Ask 0.4950 x --
- Day's Range
0.4850 - 0.5150 - 52 Week Range
0.4600 - 0.7350 - Volume
274,200 - Avg. Volume
442,103 - Market Cap (intraday)
266.219M - Beta (5Y Monthly) 0.16
- PE Ratio (TTM)
24.50 - EPS (TTM)
0.0200 - Earnings Date May 28, 2025 - Jun 4, 2025
- Forward Dividend & Yield 0.01 (2.55%)
- Ex-Dividend Date Mar 12, 2025
- 1y Target Est
0.81
Optimax Holdings Berhad, an investment holding company, provides eye specialist services and related products in Malaysia. The company's specialist centers offer a range of treatments relating to eye diseases, such as cataracts, glaucoma, conjunctivitis, age-related macular degeneration, diabetic retinopathy, retinal detachment, pterygium, keratoconus, dry eyes, and other eye diseases and disorders. It also provides services for treatment of myopia, amblyopia, and squint eyes for kids; eye examination, ortho-k specialist, and orthoptist services for kids; plastic surgery and aesthetic services; lasik surgery service; refractive surgery, consultation and dispensary, oculoplastic surgery, and eye examination services. In addition, the company markets food products; and retails pharmaceuticals, medical, orthopedic goods, perfumery, cosmetic, and toilet articles. It serves international patients from Indonesia, the Philippines, Singapore, Thailand, Australia, China, Hong Kong, and Japan. The company was founded in 1995 and is headquartered in Kuala Lumpur, Malaysia.
www.optimax2u.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 0222.KL
View MorePerformance Overview: 0222.KL
Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is FTSE Bursa Malaysia KLCI (^KLSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0222.KL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0222.KL
View MoreValuation Measures
Market Cap
263.50M
Enterprise Value
304.53M
Trailing P/E
20.55
Forward P/E
17.01
PEG Ratio (5yr expected)
0.90
Price/Sales (ttm)
2.09
Price/Book (mrq)
3.89
Enterprise Value/Revenue
2.38
Enterprise Value/EBITDA
8.20
Financial Highlights
Profitability and Income Statement
Profit Margin
10.18%
Return on Assets (ttm)
10.49%
Return on Equity (ttm)
20.30%
Revenue (ttm)
127.87M
Net Income Avi to Common (ttm)
13.02M
Diluted EPS (ttm)
0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
19.33M
Total Debt/Equity (mrq)
80.29%
Levered Free Cash Flow (ttm)
-6.38M